You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Wet age-related macular degeneration

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Intestinal Microbiome in Wet Age-related Macular Degeneration

Recruiting
  • Age-Related Macular Degeneration
  • Sample examination
  • Ioánnina, Epirus, Greece
  • +1 more
Feb 23, 2023

Age-Related Macular Degeneration Trial in Toronto (NG101 AAV gene therapy)

Not yet recruiting
  • Age-Related Macular Degeneration
  • NG101 AAV gene therapy
  • Toronto, Ontario, Canada
    Vitreous Retina Macula Specialists of Toronto
Aug 2, 2023

Data of Intravitreal Aflibercept Injection in Patients of Wet

Completed
  • Wet Age-related Macular Degeneration
  • Aflibercept (Eylea, BAY86-5321)
  • Multiple Locations, India
    Many Locations
Feb 2, 2023

Wet Age-related Macular Degeneration Trial in Beijing (RC28-E, Aflibercept)

Recruiting
  • Wet Age-related Macular Degeneration
  • Beijing, Beijing, China
    Beijing Hospital
Feb 3, 2023

Optical Coherence Tomography Angiography Criteria Of The

Not yet recruiting
  • Choroidal Neovascular Membrane In Wet Age Related Macular Degeneration And In Pathological Myopia
  • Optical coherence tomography angiography
  • (no location specified)
Sep 27, 2022

Neovascular (Wet) Age-related Macular Degeneration (nAMD) Trial (EXG102-031)

Not yet recruiting
  • Neovascular (Wet) Age-related Macular Degeneration (nAMD)
  • EXG102-031
  • (no location specified)
Jun 13, 2023

OCT Angiography in Wet AMD

Recruiting
  • Neovascular (Wet) Age-related Macular Degeneration (AMD)
  • Optical Coherence Tomography
  • Portland, Oregon
    Casey Eye Institute, Oregon Health & Science University
Sep 20, 2022

s in Wet Age-related Macular Degeneration Which Have Never

Active, not recruiting
  • Wet Age-related Macular Degeneration
  • Aflibercept (Eylea, BAY86-5321)
  • Multiple Locations, Argentina
  • +16 more
Jan 16, 2023

Wet Age-related Macular Degeneration Trial (Ranibizumab, SCT510A)

Not yet recruiting
  • Wet Age-related Macular Degeneration
  • (no location specified)
Jul 28, 2022

Wet Age-related Macular Degeneration Trial in Beijing (Aflibercept)

Completed
  • Wet Age-related Macular Degeneration
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Apr 19, 2022

Wet Age-related Macular Degeneration Trial in United States (Eyp-1901, Aflibercept 2Mg/0.05Ml Inj,Oph)

Recruiting
  • Wet Age-related Macular Degeneration
  • Melbourne, Florida
  • +4 more
Aug 18, 2022

Wet Age-related Macular Degeneration Trial in Beijing, Wuhan, Shanghai (CMAB818, Lucentis®)

Recruiting
  • Wet Age-related Macular Degeneration
  • Beijing, Beijing, China
  • +3 more
Jun 14, 2022

Neovascular (Wet) Age-related Macular Degeneration Trial (BAT5906 injection, Lucentis)

Not yet recruiting
  • Neovascular (Wet) Age-related Macular Degeneration
  • (no location specified)
Jun 26, 2022

Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in San Antonio (D-4517.2)

Recruiting
  • Neovascular Age-related Macular Degeneration
  • Diabetic Macular Edema
  • Los Angeles, California
  • +11 more
Jan 11, 2023

Neovascular (Wet) Age-related Macular Degeneration Trial (Aflibercept(BAY86-5321, Eylea))

Not yet recruiting
  • Neovascular (Wet) Age-related Macular Degeneration
  • Aflibercept(BAY86-5321, Eylea)
  • (no location specified)
Jul 22, 2022

Neovascular (Wet) Age-Related Macular Degeneration Trial in United States (4D-150 IVT, Aflibercept IVT)

Recruiting
  • Neovascular (Wet) Age-Related Macular Degeneration
  • 4D-150 IVT
  • Aflibercept IVT
  • Oxnard, California
  • +9 more
Jun 13, 2022

Healthy Volunteers, Wet Age-related Macular Degeneration Trial in Fukuoka (Placebo, KHK4951)

Recruiting
  • Healthy Volunteers
  • Wet Age-related Macular Degeneration
  • Fukuoka, Japan
    Hakata clinic
Nov 10, 2021

Neovascular Age-related Macular Degeneration Trial in United States (ADVM-022)

Recruiting
  • Neovascular Age-related Macular Degeneration
  • ADVM-022
  • Phoenix, Arizona
  • +4 more
Sep 8, 2022

Wet Age-related Macular Degeneration Trial in Boston, Worcester (Intravitreal anti-VEGF, Intravitreal AAVCAGsCD59, Oral

Completed
  • Wet Age-related Macular Degeneration
  • Intravitreal anti-VEGF
  • +2 more
  • Boston, Massachusetts
  • +1 more
May 24, 2022

Age-related Wet Macular Degeneration Trial in United States (CG-P5 peptide, Placebo, Aflibercept Injection [Eylea])

Not yet recruiting
  • Age-related Wet Macular Degeneration
  • CG-P5 peptide
  • +2 more
  • Augusta, Georgia
  • +3 more
Nov 13, 2023

Wet Age-related Macular Degeneration Trial (SCB-420, Aflibercept)

Withdrawn
  • Wet Age-related Macular Degeneration
  • (no location specified)
Apr 12, 2022

Exudative Macular Degeneration, Wet Age-related Macular Degeneration Trial in Iowa City (Doxycycline Hyclate, Placebo)

Recruiting
  • Exudative Macular Degeneration
  • Wet Age-related Macular Degeneration
  • Doxycycline Hyclate
  • Placebo
  • Iowa City, Iowa
    University of Iowa Hospitals & Clinics Department of Ophthalmolo
Apr 5, 2022

Neovascular Age-related Macular Degeneration

Completed
  • Age-related Macular Degeneration (AMD)
  • East Hanover, New Jersey
    Novartis Investigative Site
Dec 15, 2021

Diabetic Macular Edema (DME), Neovascular Age-Related Macular Degeneration (nAMD) Trial (aflibercept 8 mg PFS)

Not yet recruiting
  • Diabetic Macular Edema (DME)
  • Neovascular Age-Related Macular Degeneration (nAMD)
  • aflibercept 8 mg PFS
  • (no location specified)
Aug 3, 2023

s in Wet AMD in Active Smokers

Completed
  • Wet Age-related Macular Degeneration
  • Medical Data extraction
  • Brussels, Belgium
    CHU Brugmann
Mar 7, 2022